ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1748

Macrophage Extracellular Traps Require Peptidylarginine Deiminase 2 and 4 and Are a Source of Citrullinated Antigens Bound by Rheumatoid Arthritis Autoantibodies

S Janna Bashar, Caitlyn Holmes and Miriam Shelef, University of Wisconsin, Madison, WI

Meeting: ACR Convergence 2023

Keywords: Anti-citrullinated Protein Autoantibodies (ACPAs), citrullination, macrophages, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1734–1775) RA – Etiology and Pathogenesis Poster

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Anti-citrullinated protein antibodies (ACPAs) are a hallmark of rheumatoid arthritis, but the sources of citrullinated antigens as well as which peptidylarginine deiminases (PADs) are required for their production remain incompletely defined. Neutrophil extracellular traps (NETs) appear to be a source of citrullinated antigens bound by ACPAs, but they may not be the only source. Macrophages also generate extracellular traps (METs), but their role in rheumatoid arthritis is still emerging. The purpose of this study was to determine if METs could be a source of citrullinated proteins bound by ACPAs, and if their formation requires PAD2 or PAD4.

Methods: Thioglycolate-elicited peritoneal macrophages were isolated from wildtype, PAD2-/-, and PAD4-/- mice and were left untreated or were treated with ionomycin, monosodium urate (MSU) crystals, platelet activation factor, tumor necrosis factor alpha, lipopolysaccharide, phorbol myristate acetate, or heat killed Candida albicans. Macrophages were fixed and incubated with DAPI and either anti-citrullinated histone H4 antibody or sera from five ACPA+ or ACPA- rheumatoid arthritis subjects. Five predetermined areas of each coverslip were visualized by immunofluorescence at 400x, and METs (decondensed structures determined to be extracellular by DNase degradation studies) were counted by eye in a blinded manner. The percentage of macrophages that were METs, citrullinated METs, and ACPA-bound METs were compared between wildtype and PAD-deficient macrophages by paired t-test with p< 0.05 considered significant.

Results: Ionomycin and MSU crystals reliably induced METs with citrullinated histones. In the absence of PAD2 or PAD4, citrullinated METs were reduced, with a complete absence of citrullinated METs in PAD4-deficient macrophages. Also, IgG from ACPA+, but not ACPA- sera, bound METs. Finally, in the absence of PAD2 or PAD4, ACPA-bound METs were lost.

Conclusion: In response to ionomycin and MSU, macrophages generate citrullinated extracellular traps in a PAD4- and PAD2-dependent manner.Furthermore, ACPA+ sera can bind METs, suggesting that METs may contribute to the generation of citrullinated antigens targeted by ACPAs in rheumatoid arthritis in a PAD2- and PAD4-dependent manner.


Disclosures: S. Bashar: None; C. Holmes: None; M. Shelef: None.

To cite this abstract in AMA style:

Bashar S, Holmes C, Shelef M. Macrophage Extracellular Traps Require Peptidylarginine Deiminase 2 and 4 and Are a Source of Citrullinated Antigens Bound by Rheumatoid Arthritis Autoantibodies [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/macrophage-extracellular-traps-require-peptidylarginine-deiminase-2-and-4-and-are-a-source-of-citrullinated-antigens-bound-by-rheumatoid-arthritis-autoantibodies/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/macrophage-extracellular-traps-require-peptidylarginine-deiminase-2-and-4-and-are-a-source-of-citrullinated-antigens-bound-by-rheumatoid-arthritis-autoantibodies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology